Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6388)
All Articles published online
|
Publishing Process of This Article
|
Feb 21, 2015 (publication date) through Apr 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Casanova MJ, Chaparro M, Valenzuela C, Cisneros C, Gisbert JP. Adalimumab-induced interstitial pneumonia in a patient with Crohn’s disease. World J Gastroenterol 2015; 21(7): 2260-2262 [PMID: 25717268 DOI: 10.3748/wjg.v21.i7.2260] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i7/2260.htm |
| Number | Citing Articles |
| 1 |
Seema Alaee, Quentin Jones. Case of drug-induced interstitial lung disease secondary to adalimumab. BMJ Case Reports 2018; : bcr-2018-224375 doi: 10.1136/bcr-2018-224375
|
| 2 |
Pierre-Antoine Juge, Philippe Dieudé. Pneumopathies interstitielles diffuses au cours de la polyarthrite rhumatoïde. Revue du Rhumatisme Monographies 2018; 85(3): 153 doi: 10.1016/j.monrhu.2018.04.003
|
| 3 |
Takuya Masuda, Atsushi Yoshida, Fumiaki Ueno, Shintaro Hara, Haruaki Nabeta, Shotaro Umezawa, Mayuki Shirai, Yoshihide Morikawa, Toshio Morizane, Yutaka Endo, Toshifumi Hibi. A Patient with KL-6 Elevation with Anti-TNFα Who Could Receive Long-Term Use without Interstitial Pneumonia after Class Switch of Anti-TNFα. Inflammatory Intestinal Diseases 2019; 4(1): 35 doi: 10.1159/000497778
|
| 4 |
|
| 5 |
Pierre-Antoine Juge, Philippe Dieudé. Pneumopathies interstitielles diffuses au cours de la polyarthrite rhumatoïde. Revue du Rhumatisme Monographies 2017; 84(4): 347 doi: 10.1016/j.monrhu.2017.08.002
|
| 6 |
Igor Rakoczy, Maciej Liczek, Iga Panek, Michał Panek, Ewa Małecka-Panas, Renata Talar-Wojnarowska. PULMONARY MANIFESTATIONS OF CROHN’S DISEASE OR CHRONIC PHARMACOTHERAPY COMPLICATIONS? – CASE REPORT. Wiadomości Lekarskie 2020; 73(1): 196 doi: 10.36740/WLek202001137
|
| 7 |
Carolina Aliai Micol Cavalli, Roberto Gabbiadini, Arianna Dal Buono, Alessandro Quadarella, Alessandro De Marco, Alessandro Repici, Cristina Bezzio, Edoardo Simonetta, Stefano Aliberti, Alessandro Armuzzi. Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections. Journal of Clinical Medicine 2023; 12(19): 6419 doi: 10.3390/jcm12196419
|
| 8 |
Massimo Calderazzo, Pierandrea Rende, Paolo Gambardella, Giovambattista De Sarro, Luca Gallelli. A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment. Drug Safety - Case Reports 2015; 2(1) doi: 10.1007/s40800-015-0010-8
|
| 9 |
Anum Aqsa, Dikshya Sharma, Michel Chalhoub. Adalimumab induced interstitial lung disease. Respiratory Medicine Case Reports 2020; 29: 101012 doi: 10.1016/j.rmcr.2020.101012
|
| 10 |
Seema Alaee, Quentin Jones. Case of drug-induced interstitial lung disease secondary to adalimumab. Drug and Therapeutics Bulletin 2018; 56(12): 150 doi: 10.1136/dtb.2018.12.224375rep
|